FDA Inspection 1219483 — Laboratorios Liomont, S.A. de C.V.
The FDA completed an inspection of Laboratorios Liomont, S.A. de C.V. on August 4, 2023 in Ciudad De Mexico. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- August 4, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ciudad De Mexico (Mexico)